Incyte Corporation
NASDAQ:INCY
Overview | Financials
Company Name | Incyte Corporation |
Symbol | INCY |
Currency | USD |
Price | 80.58 |
Market Cap | 15,523,737,000 |
Dividend Yield | 0% |
52-week-range | 50.35 - 83.95 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Herve Hoppenot |
Website | https://www.incyte.com |
An error occurred while fetching data.
About Incyte Corporation
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD